FDA OKs Liptruzet for High LDL

(MedPage Today) -- The FDA approved Liptruzet, a combination of ezetimibe and atorvastatin, for the treatment of hyperlipidemia, drug maker Merck announced today.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news